Insider Selling: OmniAb, Inc. (NASDAQ:OABI) CFO Sells $26,625.85 in Stock

OmniAb, Inc. (NASDAQ:OABI) CFO Kurt A. Gustafson sold 7,255 shares of the business’s stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $3.67, for a total value of $26,625.85. Following the transaction, the chief financial officer now directly owns 206,211 shares of the company’s stock, valued at $756,794.37. The trade was a 3.40 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

OmniAb Price Performance

Shares of NASDAQ OABI opened at $3.65 on Friday. The company has a market capitalization of $515.45 million, a price-to-earnings ratio of -5.89 and a beta of -0.12. The business has a 50-day moving average of $3.48 and a two-hundred day moving average of $3.90. OmniAb, Inc. has a 1 year low of $3.10 and a 1 year high of $6.55.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. Benchmark reissued a “buy” rating and set a $8.00 target price on shares of OmniAb in a research note on Thursday, November 14th. HC Wainwright reaffirmed a “buy” rating and set a $11.00 price target on shares of OmniAb in a report on Thursday, November 14th.

Institutional Trading of OmniAb

Several institutional investors and hedge funds have recently made changes to their positions in the company. Janus Henderson Group PLC lifted its holdings in shares of OmniAb by 1.1% in the 4th quarter. Janus Henderson Group PLC now owns 7,960,321 shares of the company’s stock valued at $28,179,000 after purchasing an additional 88,993 shares during the last quarter. Dimensional Fund Advisors LP increased its position in OmniAb by 4.9% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,025,674 shares of the company’s stock worth $10,711,000 after purchasing an additional 142,513 shares during the period. Rice Hall James & Associates LLC increased its position in OmniAb by 6.4% during the 3rd quarter. Rice Hall James & Associates LLC now owns 2,722,321 shares of the company’s stock worth $11,515,000 after purchasing an additional 163,038 shares during the period. Geode Capital Management LLC grew its holdings in shares of OmniAb by 1.2% in the 4th quarter. Geode Capital Management LLC now owns 2,353,442 shares of the company’s stock worth $8,333,000 after acquiring an additional 28,061 shares during the period. Finally, State Street Corp grew its holdings in shares of OmniAb by 1.7% in the 3rd quarter. State Street Corp now owns 2,031,676 shares of the company’s stock worth $8,594,000 after acquiring an additional 34,654 shares during the period. 72.08% of the stock is owned by hedge funds and other institutional investors.

About OmniAb

OmniAb, Inc, a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts.